Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy Beam
- 1 January 2013
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 179 (1), 21-28
- https://doi.org/10.1667/rr2737.1
Abstract
Considerable evidence now exists to show that that the relative biological effectiveness (RBE) changes considerably along the proton depth-dose distribution, with progressively higher RBE values at the distal part of the modulated, or spread out Bragg peak (SOBP) and in the distal dose fall-off (DDF). However, the highly variable nature of the existing studies (with regards to cell lines, and to the physical properties and dosimetry of the various proton beams) precludes any consensus regarding the RBE weighting factor at any position in the depth-dose profile. We have thus conducted a systematic study on the variation in RBE for cell killing for two clinical modulated proton beams at Indiana University and have determined the relationship between the RBE and the dose-averaged linear energy transfer (LETd) of the protons at various positions along the depth-dose profiles. Clonogenic assays were performed on human Hep2 laryngeal cancer cells and V79 cells at various positions along the SOBPs of beams with incident energies of 87 and 200 MeV. There was a marked variation in the radiosensitivity of both cell lines along the SOBP depth-dose profile of the 87 MeV proton beam. Using Hep2 cells, the D(0.1) isoeffect dose RBE values (normalized against (60)Co) were 1.46 at the middle of SOBP, 2.1 at the distal end of the SOBP and 2.3 in the DDF. For V79 cells, the D(0.1) isoeffect RBE for the 87 MEV beam were 1.23 for the proximal end of the SOBP: 1.46 for the distal SOBP and 1.78 for the DDF. Similar D(0.1) isoeffect RBE values were found for Hep2 cells irradiated at various positions along the depth-dose profile of the 200 MeV beam. Our experimentally derived RBE values were significantly correlated (P = 0.001) with the mean LETd of the protons at the various depths, which confirmed that proton RBE is highly dependent on LETd. These in vitro data suggest that the RBE of the proton beam at certain depths is greater than 1.1, a value currently used in most treatment planning algorithms. Thus, the potential for increased cell killing and normal tissue damage in the distal regions of the proton SOBP may be greater than originally thought.Keywords
This publication has 24 references indexed in Scilit:
- Radiobiological Characterization of Two Therapeutic Proton Beams With Different Initial Energy Spectra Used at the Institut Curie Proton Therapy Center in OrsayInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beamInternational Journal of Radiation Biology, 2006
- Immobilization and dose-sparing effects of a rectal balloon in conformal proton radiotherapy of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Radiobiological studies on the 65MeV therapeutic proton beam at Nice using human tumour cellsInternational Journal of Radiation Biology, 2000
- Inactivation of human normal and tumour cells irradiated with low energy protonsInternational Journal of Radiation Biology, 2000
- RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facilityInternational Journal of Radiation Biology, 1998
- Comparison of radiobiological effective depths in 65-MeV modulated proton beamsBritish Journal of Cancer, 1997
- Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ionsInternational Journal of Radiation Biology, 1996
- The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protonsThe British Journal of Radiology, 1994
- Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell linesRadiotherapy and Oncology, 1993